Addressing challenges in mRNA drug development and manufacturing
The rapid development and approval of COVID-19 vaccines spurred renewed interest in mRNA technology, but despite its advantages, specific challenges still exit:
Read the following interactive article to explore these challenges and their potential solutions.
© 2023 Thermo Fisher Scientific Inc. All rights reserved. All trademarks are the property of Thermo Fisher Scientific and its subsidiaries unless otherwise specified. We hereby disclose that this email communication is for commercial purposes.